Immunohistochemical Expression of p53 Gene and Clinicopathological Assessment of Low-grade Serous Ovarian Cancer and High-grade Serous Ovarian Cancer: A Cohort Study
Introduction: Ovarian cancer is a significant global health concern for women. More than 85-90% of ovarian cancer cases originates from epithelial causes. Dysfunctional p53 is a hallmark of many cancers, including ovarian cancer. Alteration in functioning of p53 gene has been connected to the onset...
Saved in:
Main Authors: | Geeta Bazard, Minakshi Vashist, Sunita Singh, Gulshan Rohilla, Nidhi Paliwal |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2024-12-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/20446/74248_CE[Ra1]_F(SL)_QC(SD_IS)_PF1(AG_SL)_redo_PFA(IS)_PB(AG_IS)_PN(IS).pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction
by: Oz Kilim, et al.
Published: (2025-01-01) -
Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma
by: Kristina Mae Bienes, et al.
Published: (2025-01-01) -
Clinicopathological and prognostic factor analyses of primary fallopian tube carcinoma and high-grade serous ovarian cancer: a single-institution retrospective study
by: Mengyan Tu, et al.
Published: (2025-01-01) -
Pancreatic Metastasis of High-Grade Papillary Serous Ovarian Carcinoma Mimicking Primary Pancreas Cancer: A Case Report
by: Yusuf Gunay, et al.
Published: (2012-01-01) -
Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translation
by: Aline Talhouk, et al.
Published: (2025-01-01)